Stockreport

LifeSci Capital Reiterates a Buy on Olema Pharmaceuticals (OLMA) [Yahoo! Finance]

Olema Pharmaceuticals, Inc.  (OLMA) 
PDF Capital reiterated a Buy rating on the stock and raised the price target from $39 to $45. Earlier, on January 14, Kelsey Goodwin from Piper Sandler reiterated a Buy rati [Read more]